Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Pfizer has informed that upon recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company at its meeting held today appointed Amit Agarwal as the Chief Financial Officer of the Company effective February 26, 2024. Further, upon recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company at its meeting held today, also appointed Amit Agarwal (DIN: 10465938) as an Additional Director (Whole-time Director) of the Company, designated as Executive Director – Finance & Chief Financial Officer for a period of 5 years with effect from February 26, 2024. The said appointment shall be subject to the approval of shareholders. Additional details required to be disclosed pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular Nos. SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023, and List/Comp/14/2018-19 dated June 20, 2018, are enclosed as Annexure A.
The above information is a part of company’s filings submitted to BSE.